Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eisai Inc.
City of Hope Medical Center
M.D. Anderson Cancer Center
Sotio Biotech Inc.
GlaxoSmithKline